Please turn JavaScript on

Drug Policy Facts - Knowledge is power

follow.it gives you an easy way to subscribe to Drug Policy Facts - Knowledge is power's news feed! Click on Follow below and we deliver the updates you want via email, phone or you can read them here on the website on your own news page.

You can also unsubscribe anytime painlessly. You can even combine feeds from Drug Policy Facts - Knowledge is power with other site's feeds!

Title: Drug Policy Facts | Drug Policy Facts

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.19 / day

Message History

Psilocybin Therapy for Patients With Cancer and Major Depression Disorder

"A total of 30 participants were enrolled and completed the study per protocol; the attrition rate was 0%. The mean (SD) age was 56 (12) years with 9 (30%) men and 21 (70%) women (


Read full story
Methylone (3,4-methylenedioxy-N-methylcathinone)

"Methylone (3,4-methylenedioxy-N-methylcathinone), also known as MDMC, βk-MDMA, or M1, is a synthetic cathinone that emerged in 2004 as a new psychoactive substance (NPS), although first synthesized in 1996 and planned for therapeutic use as an antidepressant and potential treatment for the Parkinson’s disease (Bosso...


Read full story
Growth of Nitazenes in the US's Unregulated Drug Supply "Findings

"Between 2019 and 2024, 7117 nitazene analog reports were submitted to NFLIS, increasing from 43 in 2019 to 1905 in 2024. Counts rose sharply from 2019 to 2021 [count ratio = 7.32; 95% confidence interval (CI) = 2.22–24.20] but did not increase statistically significantly from 2021 to 2024 (count ratio = 1.08;...


Read full story